Emrah Küçük

Dr. Emrah Küçük

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
AŞALPER ŞİMŞEK
ALPER ŞİMŞEK
MDMesut Berkan Duran
Mesut Berkan Duran
MAMustafa Aydın
Mustafa Aydın
HYHakan Yıldız
Hakan Yıldız
ROReha Ordulu
Reha Ordulu
MAMustafa Kemal Atilla
Mustafa Kemal Atilla

1 January 2023 in Urology Research and Practice
Verified
Journal Article
Open access
MKMustafa Koray Kırdağ
Mustafa Koray Kırdağ
IOIsa Ozbey
Isa Ozbey
EOEser Ordek
Eser Ordek
AOAhmet Olgun
Ahmet Olgun
MOMehmet Sezai Ogras
Mehmet Sezai Ogras
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
Objective: The aim of this study is to evaluate current urologic practice regarding the management of priapism in Turkey and compare with international guidelines. Methods: Urologists and urology residents were invited to an online survey consisting of 30 multiple-choice questions on priapism-related clinical practices that were consid- ered most important and relevant to practices by using Google Forms. Results: Total number of responses was 340. Respondents reported that they recorded a detailed patient’s medical history and physical examination findings (n = 340, 100%) and laboratory testing, which includes corporal blood gas analysis (n=323, 95%). Participants announced that they performed Doppler ultrasound for 1/4 cases (n = 106, 31%), but 22% of the participants (n=75) replied that they performed in >75% of cases. Participants (n=311, 91%) responded that the first-line treatment of ischemic priapism is decompression of the corpus cavernosum. Moreover, most respondents (n = 320, 94%) stated that sympathomimetic injection drugs should be applied as the second step. About three-quarters of respondents (n = 247, 73%) indicated adrenaline as their drug of choice. Phosphodiesterase type 5 inhibitors seems to be the most pre- ferred drug for stuttering priapism (n=141, 41%). Participants (n=284, 84%) replied that corpora-glanular shunts should be preferred as the first. A large number of par- ticipants (n = 239, 70%) declared that magnetic resonance imaging can be performed in cases with delayed (>24 hours) priapism to diagnose corporal necrosis. Most of the participants (84%) responded that penile prosthesis should be preferred to shunts in cases with delayed (>48 hours) priapism. Conclusion: It would be appropriate to improve the training offered by professional associations and to give more training time to the management of priapism during residency. Cite this article as: Kalkanli A, Zeki Sönmez S, Guvel M, et al. Management of priapism: Results of a nationwide survey and comparison with international guidelines. Urol Res Pract. 2023;49(4):225-232.

17 February 2026 in BMC Urology
Verified
Journal Article
Open access
PDF file
EKEmrah Küçük
Emrah Küçük
HGHaydar Güler
Haydar Güler
ROReha Ordulu
Reha Ordulu
MAMustafa Aydın
Mustafa Aydın
UÖUğur Öztürk
Uğur Öztürk
MAMustafa Kemal Atilla
Mustafa Kemal Atilla
This study aimed to assess the independent effect of diabetes mellitus (DM) on ureteral stone access and surgical outcomes in patients undergoing ureterosc

1 March 2023 in Üroonkoloji Bülteni
Verified
Journal Article
Open access
RIRamazan İnan
Ramazan İnan
ABAlper Bitkin
Alper Bitkin
MAMustafa Aydın
Mustafa Aydın
EKEmrah Küçük
Emrah Küçük
MAMustafa Kemal Atilla
Mustafa Kemal Atilla
LILokman İrkilata
Lokman İrkilata

27 April 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
PDF file
EKEmrah Küçük
Emrah Küçük
AAAhmet Furkan Akıllı
Ahmet Furkan Akıllı
ROReha Ordulu
Reha Ordulu
MŞMesut Şengül
Mesut Şengül
MKMuhammed Esad Kayhan
Muhammed Esad Kayhan
MAMustafa Kemal Atilla
Mustafa Kemal Atilla
Objective: To evaluate the association between vacuum-assisted closure therapy and clinical outcomes, particularly mortality, in patients surgically treated for Fournier’s gangrene. Methods: This retrospective cohort study included 268 patients treated for Fournier’s gangrene between 2015 and 2025. Patients were divided into two groups: debridement alone (Group 1, n = 160) and debridement plus vacuum-assisted closure therapy (Group 2, n = 108). Demographic characteristics, comorbidities, laboratory findings, Fournier Gangrene Severity Index, intensive care unit admission, additional surgical procedures, length of stay, and mortality were compared. Multivariate logistic regression was performed to identify independent predictors of mortality. Results: Observed mortality was lower in the vacuum-assisted closure therapy group than in the debridement-only group (7.4% vs. 16.9%, p = 0.038). However, multivariate analysis demonstrated that only intensive care unit admission (OR 6.40, 95% CI 1.52–26.89, p = 0.011) and Fournier Gangrene Severity Index score (OR 5.57, 95% CI 2.91–10.71, p < 0.001) were independently associated with mortality. Vacuum-assisted closure therapy was not an independent predictor (OR 0.58, 95% CI 0.16–2.10, p = 0.409). The vacuum-assisted closure therapy group underwent more debridement procedures and had a longer hospital stay. Conclusion: Although vacuum-assisted closure therapy was associated with lower unadjusted mortality, survival was primarily determined by disease severity and intensive care unit admission. Vacuum-assisted closure therapy may improve wound management; however, its impact on survival appears influenced by baseline clinical status. Prospective studies are needed to clarify its role in Fournier’s gangrene management.